Fluorescence Lifetime Imaging of NAD(P)H in Patients’ Lymphocytes: Evaluation of Efficacy of Immunotherapy

Fluorescence Lifetime Imaging of NAD(P)H in Patients’ Lymphocytes: Evaluation of Efficacy of Immunotherapy

Background: The wide variability in clinical responses to anti-tumor immunotherapy drives the search for personalized strategies. One of the promising approaches is drug screening using patient-derived models composed of tumor and immune cells. In this regard, the selection of an appropriate in vitr...

Full description

Saved in:

Bibliographic Details
Main Authors:	Diana V. Yuzhakova, Daria A. Sachkova, Anna V. Izosimova, Konstantin S. Yashin, Gaukhar M. Yusubalieva, Vladimir P. Baklaushev, Artem M. Mozherov, Vladislav I. Shcheslavskiy, Marina V. Shirmanova
Format:	Article
Language:	English
Published:	MDPI AG 2025-01-01
Series:	Cells
Subjects:	immunotherapy immune-checkpoint inhibitor ICI personalized therapy tumor explant lymphocyte glioma
Online Access:	https://www.mdpi.com/2073-4409/14/2/97
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Targeting RGMb interactions: Discovery and preclinical characterization of potent anti-RGMb antibodies blocking multiple ligand bindings
by: Maria Meira, et al.
Published: (2024-12-01)

Immune checkpoint inhibitors-related thyroid dysfunction: influencing factor analysis, prediction model development, and management strategy proposal
by: Xinya Li, et al.
Published: (2024-11-01)

Efficacy of high-dose steroids versus low-dose steroids in the treatment of immune checkpoint inhibitor-associated myocarditis: a case series and systematic review
by: Xiuyue Man, et al.
Published: (2025-02-01)

Increased PD-1 expression in livers associated with PD-1-antibody-induced hepatotoxicity
by: Miro Saarela, et al.
Published: (2025-01-01)

Editorial: Beyond PD-1: novel checkpoint receptors and ligands as targets for immunotherapy
by: Jesse Haramati, et al.
Published: (2025-02-01)

Efficiency of <i>in vitro</i> culture techniques applied to soybean (<i>Glycine max (L.) Merr.</i>) accessions from the VIR collection
by: E. S. Korshikova, et al.
Published: (2021-12-01)

Anti-HER2 biparatopic antibody KJ015 has near-native structure, functional balanced high affinity, and synergistic efficacy with anti-PD-1 treatment in vivo
by: Zheng Wang, et al.
Published: (2024-12-01)

Prediction-based prompt levothyroxine replacement to prevent a hypothyroid state after immune-related adverse events involving the thyroid gland
by: Ichiro Yamauchi, et al.
Published: (2023-10-01)

Clinical characteristics and potential biomarkers of thyroid and pituitary immune-related adverse events
by: Tomoko Kobayashi, et al.
Published: (2024-01-01)

Infectivity in full-term placenta of Zika viruses with different lipid profiles
by: Eva Mazzetto, et al.
Published: (2025-02-01)

Exploring the therapeutic effect of human recombinant IL11 on lesioned OA human osteochondral explants
by: Margo Tuerlings, et al.
Published: (2025-01-01)

Electrochemical sensors for the detection of immune checkpoint related proteins and their role in cancer companion diagnostics
by: Louise Barnaby, et al.
Published: (2025-03-01)

Results of propagation of Fagus silvatica L. plants in vitro
by: Mykola Lisovyi, et al.
Published: (2024-09-01)

Study of Seaweed Kappaphycus alvarezii Explants Growth in the Different Salinity Concentrations
by: Muhammad Aris, et al.
Published: (2021-03-01)

Endocrine Adverse Events in Patients Treated with Immune Checkpoint Inhibitors: A Comprehensive Analysis
by: Meriç Dökmetaş, et al.
Published: (2025-01-01)

Efficacy and safety of PD-1 inhibitors as second-line treatment for advanced squamous esophageal cancer: a systematic review and network meta-analysis with a focus on PD-L1 expression levels
by: Fei Yang, et al.
Published: (2025-01-01)

CSF3R as a potential prognostic biomarker and immunotherapy target in glioma
by: Minglei Huang, et al.
Published: (2024-06-01)

Baseline (derived) neutrophil-lymphocyte ratio associated with survival in gastroesophageal junction or gastric cancer treated with ICIs
by: Chengyang Yu, et al.
Published: (2025-01-01)

Interdependence of coagulation with immunotherapy and BRAF/MEK inhibitor therapy: results from a prospective study
by: Malte Beckmann, et al.
Published: (2024-11-01)

A positive experience in applying the biolistic approach to potato varieties Aksor and Nevskiy
by: N. P. Malakhova, et al.
Published: (2021-04-01)

Editorial: Tertiary lymphoid structures (TLS) in the tumor immune microenvironment
by: Xinbo Gao, et al.
Published: (2025-01-01)

THE MORPHOGENIC POTENTIAL OF SIBERIAN POTATO CULTIVARS IN TISSUE CULTURES
by: S. M. Ibragimova, et al.
Published: (2018-05-01)

Challenges of in vitro conservation of Сitrus germplasm resources
by: V. M. Gorshkov, et al.
Published: (2019-02-01)

<i>In vitro</i> regeneration of soybean (a review)
by: E. S. Bespalova, et al.
Published: (2021-12-01)

Outcomes of patients after successful left ventricular assist device explantation: a EUROMACS study
by: Christiaan F.J. Antonides, et al.
Published: (2020-06-01)

New T-lymphocyte subpopulations and their characteristics: Challenges to the classical division of lymphocyte function
by: Filip Lewandowski, et al.
Published: (2024-11-01)

A Journey into the Complexity of Temporo-Insular Gliomas: Case Report and Literature Review
by: Manuel De Jesus Encarnacion Ramirez, et al.
Published: (2025-01-01)

Lymphocyte levels in Crohn’s disease patients in clinical remission are significantly lower than those in healthy people
by: Asi He, et al.
Published: (2025-02-01)

Effects of radiation and manganese oxide nanoparticles on human glioblastoma cell line U-87 MG glycolysis
by: N. B. Illarionova, et al.
Published: (2019-02-01)

Development and validation of a nomogram for predicting immune-mediated colitis in lung cancer patients treated with immune checkpoint inhibitors: a retrospective cohort study in China
by: Qianjie Xu, et al.
Published: (2025-01-01)

Gut Microbiota–Tumor Microenvironment Interactions: Mechanisms and Clinical Implications for Immune Checkpoint Inhibitor Efficacy in Cancer
by: Said SS, et al.
Published: (2025-01-01)

Serum KL-6 levels reflect the severity of interstitial lung disease caused by immune checkpoint inhibitors
by: Xiaoping Li, et al.
Published: (2025-01-01)

The clinical significance of T cell infiltration and immune checkpoint expression in central nervous system germ cell tumors
by: Jiajun Zhou, et al.
Published: (2025-01-01)

V-ATPase in glioma stem cells: a novel metabolic vulnerability
by: Alessandra Maria Storaci, et al.
Published: (2025-01-01)

An exceptionally rare case of a diffuse midline glioma with concomitant H3.1 K27M and G34R mutations in the HIST1H3C (H3C3) gene
by: Zita Reisz, et al.
Published: (2025-01-01)

The lymphocyte levels of Hashimoto thyroiditis patients were significantly lower than that of healthy population
by: Hui Xue, et al.
Published: (2025-01-01)

A Review on Intra-organizational Relations
by: Alev Özer Torgalöz
Published: (2018-11-01)

Prediction of Survival Outcomes in Patients with Glioma Using Magnetic Resonance Imaging (MRI): A Systematic Review and Meta-Analysis
by: Mingfang Hu, et al.
Published: (2025-01-01)

Beyond Benign: A Case of Subependymal Giant Cell Astrocytomas Provoking Hydrocephalus in Tuberous Sclerosis Complex
by: Antonio Navarro-Ballester, et al.
Published: (2024-05-01)

Antiviral therapy can effectively suppress irAEs in HBV positive hepatocellular carcinoma treated with ICIs: validation based on multi machine learning
by: Shuxian Pan, et al.
Published: (2025-01-01)